Serum amyloid A‐derived peptides, present in human rheumatic synovial fluids, induce the secretion of interferon‐γ by human CD4+ T‐lymphocytes

Authors:
  • LPLiana Preciado-Patt
    Liana Preciado-Patt
  • OROren Rosen
    Oren Rosen
  • MYMichael Yaron
    Michael Yaron
  • RSRoderich D. Suessmuth
    Roderich D. Suessmuth
  • DLDavid Levartowsky
    David Levartowsky
  • GJGunther Jung
    Gunther Jung
  • OLOfer Lider
    Ofer Lider
  • MFMati Fridkin
    Mati Fridkin

Abstract
Serum amyloid A (SAA) is a major acute‐phase protein whose biochemical functions remain largely obscure. Human rheumatic synovial fluids were screened by high performance liquid chromatography mass spectrometry for SAA‐derived peptides, specifically the sequence AGLPEKY (SAA98–104) which was previously shown to modulate various leukocyte functions. Two such fluids were found to contain a truncated version of SAA98–104. Synthetic SAA98–104 and several of its analogs were shown capable of binding isolated human CD4 + T‐lymphocytes and stimulating them to produce interferon‐γ. Given the high acute‐phase serum level of SAA and its massive proteolysis by inflammatory related enzymes, SAA‐derived peptides may be involved in host defense mechanisms.

This publication has 11 references indexed in Scilit: